Tennessee halts Rx drug program enrollment

5 March 2007

Tennessee's new CoverRx prescription drug plan for low-income residents of the southern state has suspended enrollment, after almost 21,000 people signed up by February 8. The program's organizers explained that the total $11.5 million budget for the CoverRx scheme was expected to cover 25,000-50,000 people in the 2007 fiscal year. The program is one of three Cover Tennessee health insurance programs launched by Governor Phil Bredesen (Democrat) as part of his attempt to overhaul the troubled TennCare health care service.

A recent study found that Tennessee has the highest level of prescription drug use per capita of any US state (Marketletter February 19) with an average of 17.3 prescriptions per person annually, compared with 11.3 for the USA as a whole.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight